Skip to main content

Table 3 Five-year relative survival rates for different racial groups, stratified by age, gender, and stage at diagnosis

From: Racial differences in mantle cell lymphoma in the United States

 

Total (n = 5438)

Non-Hispanic white (n = 4458)

Hispanic white (n = 446)

Black (n = 241)

Asian/PI (n = 219)

P-value

n

Rate (95% CI)

n

Rate (95% CI)

n

Rate (95% CI)

n

Rate (95% CI)

n

Rate (95% CI)

Age group

          

<40 years

75

78.0 (64.8-86.7)

48

84.7 (69.6-92.7)

12

66.8 (26.5-88.5)

11

45.5 (7.8-78.4)

3

100.0

0.7

40-64 years

2257

61.9 (59.4-64.3)

1802

63.1 (60.3-65.8)

202

51.4 (42.3-59.7)

126

58.0 (46.8-67.6)

97

61.2 (48.8-71.4)

0.523

65+ years

3106

43.2 (40.7-45.7)

2608

44.4 (41.7-47.1)

232

35.5 (26.5-44.6)

104

34.9 (22.5-47.5)

119

41.2 (29.7-52.3)

0.762

Gender

          

Male

3740

51.2 (49.0-53.3)

3062

52.2 (49.8-54.5)

330

43.6 (36.0-50.9)

152

49.5 (39.0-59.2)

148

46.6 (36.4-56.2)

0.487

Female

1698

53.1 (49.9-56.1)

1396

54.9 (51.9-57.9)

116

44.4 (32.6-55.5)

89

45.4 (31.9-58.0)

71

59.5 (44.2-71.9)

0.259

Stage at diagnosis

         

Stage I

633

72.6 (67.2-77.2)

518

72.9 (66.9-78.0)

46

64.2 (40.6-80.3)

27

72.1 (41.6-88.5)

33

73.7 (51.2-87.0)

0.604

Stage II

447

59.0 (52.7-64.8)

365

59.7 (52.6-66.0)

36

42.1 (18.7-64.0)

17

46.0 (14.4-73.2)

24

72.2 (45.3-87.5)

0.983

Stage III

780

45.6 (40.7-50.2)

625

46.0 (40.6-51.2)

70

39.1 (24.6-53.3)

50

40.4 (23.2-57.0)

28

62.0 (37.1-79.4)

0.143

Stage IV

3243

47.9 (45.6-50.1)

2690

49.0 (46.5-51.5)

263

39.8 (31.8-47.7)

131

45.4 (34.2-55.9)

125

37.6 (26.6-48.5)

0.063

  1. Cancers diagnosed in the period of 1992–2004 and followed up to 12/31/2009 in the SEER 18 database. In each cell, estimated rate (95% CI). P-values were generated from multivariate Cox models. Details are provided in Additional file 1.